# Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients

> **NCT05980611** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 75 (estimated)

## Conditions studied

- Copd Patients

## Interventions

- **DIAGNOSTIC_TEST:** IL B,IL 3 in nasal swap and serum

## Key facts

- **NCT ID:** NCT05980611
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09
- **Primary completion:** 2024-09
- **Final completion:** 2024-12
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2023-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05980611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05980611, "Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05980611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*